Brief: Quantum Genomics Enrolls First Patient In Quorum Phase IIb Study
06/06/2019 17:02
June 6 (Reuters) - Quantum Genomics SA ALQGC.PA :
* QUANTUM GENOMICS ENROLLS FIRST PATIENT IN QUORUM PHASE IIB
STUDY
OF FIRIBASTAT IN HEART FAILURE PATIENTS
Source text for Eikon: ID:nGNX9vFyt9
Further company coverage: ALQGC.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Quantum Genomics SA
See all newsBrief: Quantum Genomics Announces Resumption Of Discussions With HealthTech, Terminates Exclusive Negotiations With Vistacare Medical
Brief: Quantum Genomics Enters Into Exclusive Negotiations With Vistacare Medical
Brief: Quantum Genomics To Reduce Staff; Jean-Philippe Milon Becomes President and CEO
Brief: Quantum Genomics In Talks For New Strategic Project
Brief: Quantum Genomics Announces Lack Of Significant Efficacy For Firibastat In Their Phase Iii Study